$61.92 -0.38 (%) Bristol-Myers Squibb Co - NYSE

Mar. 3, 2015 | 04:00 PM

Partner Headlines

  1. Bristol-Myers Squibb Canada Announces Hepatitis C Cure Rate of 97% in Study of Patients Co-infected with HIV Given 12-week Combination Treatment of Daclatasvir and Sofosbuvir in ALLY-2 Trial

    Benzinga | Mar. 3, 2015 | 06:22AM EST
  2. UPDATE: USDA Approves Supplimental Biologics License

    Benzinga | Mar. 2, 2015 | 09:28AM EST
  3. USDA Accepts Supplemental Biologics License Application for Yervoy As Adjuvant Treatment for Patients with Stage 3 Melanoma Who Are at High Risk of Recurrence

    Benzinga | Mar. 2, 2015 | 09:27AM EST
  4. Bristol Myers Reports Data Supporting Clinical Development Of BMS-955176

    Benzinga | Feb. 26, 2015 | 08:35AM EST
  5. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  6. Bristol-Myers Squibb Launches Phase III Trial Of HIV Drug

    Benzinga | Feb. 25, 2015 | 12:57PM EST
  7. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD | Feb. 24, 2015 | 15:58PM EST
  8. Bristol-Myers goes for the gut

    IBD | Feb. 23, 2015 | 18:33PM EST
  9. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  10. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  11. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  12. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST
  13. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga | Feb. 23, 2015 | 07:34AM EST
  14. Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices

    Benzinga | Feb. 20, 2015 | 13:10PM EST
  15. Strong Dollar Weakens Views

    IBD | Jan. 27, 2015 | 18:48PM EST
  16. Drugmakers Warn On Dollar

    IBD | Jan. 27, 2015 | 18:47PM EST
  17. Strong Dollar Pins U.S. Corporate Earnings Outlook

    IBD | Jan. 27, 2015 | 18:29PM EST
  18. Drug Firms Report Good Q4, But Outlook Cloudy

    IBD | Jan. 27, 2015 | 18:10PM EST
  19. Strong Dollar Means Flabby Outlook For Some Overseas

    IBD | Jan. 27, 2015 | 13:45PM EST
  20. Bristol, Pfizer, Novartis Forecasts Face FX Pressures

    IBD | Jan. 27, 2015 | 11:57AM EST
  21. Tuesday Morning Movers: Microsoft, Procter & Gamble Tumble Following Earnings

    Benzinga | Jan. 27, 2015 | 09:19AM EST
  22. UPDATE: Bristol-Meyers Squibb Posts Upbeat Q4 Results, Issues Downbeat Forecast

    Benzinga | Jan. 27, 2015 | 08:39AM EST
  23. Earnings Scheduled For January 27, 2015

    Benzinga | Jan. 27, 2015 | 04:34AM EST
  24. Pharmaceuticals Sector To See High Voltage Action in 2015

    GuruFocus | Jan. 23, 2015 | 16:13PM EST
  25. 3 High-Flying Health Care Stock IPOs To Watch In 2015

    IBD | Jan. 21, 2015 | 17:09PM EST
  26. BRISTOL-MYERS SQUIBB

    IBD | Jan. 20, 2015 | 18:44PM EST
  27. Bristol-Myers Squibb Names Caforio CEO, Andreotti To Become Chairman

    Benzinga | Jan. 20, 2015 | 17:09PM EST
  28. Feeling Good With This Med Company

    GuruFocus | Jan. 20, 2015 | 15:12PM EST
  29. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  30. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD | Jan. 15, 2015 | 11:02AM EST
  31. Celgene Outlook Is Upbeat

    IBD | Jan. 12, 2015 | 18:58PM EST
  32. Celgene, Bristol-Myers Cancer Drug News Lifts Stocks

    IBD | Jan. 12, 2015 | 18:48PM EST
  33. Bristol-Myers Hits 14-Year High On Cancer Drug Trial

    IBD | Jan. 12, 2015 | 14:25PM EST
  34. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  35. Morning Market Gainers

    Benzinga | Jan. 12, 2015 | 09:42AM EST
  36. Credit Suisse: Keep An Eye On These 6 Healthcare Stocks In 2015

    Benzinga | Jan. 11, 2015 | 12:59PM EST
  37. What Investors Should Expect From Portola Pharmaceutical's Upcoming Data Readouts

    Benzinga | Jan. 9, 2015 | 12:43PM EST
  38. Jim Cramer Advises His Viewers On Wynn Resorts And Second Sight Medical Products

    Benzinga | Jan. 6, 2015 | 07:53AM EST
  39. Bristol-Myers Squibb and California Institute for Biomedical Research Sign Worldwide Research Collaboration and License Agreement Focused on New Treatment Approaches for Fibrotic Diseases

    Benzinga | Jan. 5, 2015 | 08:01AM EST
  40. 5 Biotech Stocks With Big News Due In January

    IBD | Dec. 31, 2014 | 13:15PM EST
  41. FDA's OKs may prescribe hits

    IBD | Dec. 26, 2014 | 18:49PM EST
  42. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  43. Meet 5 Top Biotech Stocks Holding Up In Shaky Market

    IBD | Dec. 13, 2014 | 08:02AM EST
  44. Celgene drug could gain share

    IBD | Dec. 11, 2014 | 19:00PM EST
  45. Celgene's Abraxane Succeeds In Early Breast Cancer

    IBD | Dec. 11, 2014 | 11:27AM EST
  46. Merck's Keytruda Might Treat Virulent Breast Cancer

    IBD | Dec. 10, 2014 | 11:04AM EST
  47. US Stock Futures Edge Lower Ahead Of Federal Budget

    Benzinga | Dec. 10, 2014 | 07:01AM EST
  48. T Rowe Price's Top Stakes for the Third Quarter

    GuruFocus | Dec. 9, 2014 | 10:16AM EST
  49. I think Zimmer Will Outperform S&P 500 Performance

    GuruFocus | Dec. 4, 2014 | 10:06AM EST
  50. Avanir Stock Jumps On $3.5 Billion Otsuka Buyout

    IBD | Dec. 2, 2014 | 11:22AM EST
Trading Center